Barriers and Facilitators to Artificial Intelligence Implementation in Diabetes Management from Healthcare Workers’ Perspective: A Scoping Review
Open accessAbstract
Background and Objectives: Diabetes is a global public health challenge, with increasing prevalence worldwide. The implementation of artificial intelligence (AI) in the management of this condition offers potential benefits in improving healthcare outcomes. This study primarily investigates the barriers and facilitators perceived by healthcare professionals in the adoption of AI. Secondarily, by analyzing both quantitative and qualitative data collected, it aims to support the potential development of AI-based programs for diabetes management, with particular focus on a possible bottom-up approach. Materials and Methods: A scoping review was conducted following PRISMA-ScR guidelines for reporting and registered in the Open Science Framework (OSF) database. The study selection process was conducted in two phases—title/abstract screening and full-text review—independently by three researchers, with a fourth resolving conflicts. Data were extracted and assessed using Joanna Briggs Institute (JBI) tools. The included studies were synthesized narratively, combining both quantitative and qualitative analyses to ensure methodological rigor and contextual depth. Results: The adoption of AI tools in diabetes management is influenced by several barriers, including perceived unsatisfactory clinical performance, high costs, issues related to data security and decision-making transparency, as well as limited training among healthcare workers. Key facilitators include improved clinical efficiency, ease of use, time-saving, and organizational support, which contribute to broader acceptance of the technology. Conclusions: The active and continuous involvement of healthcare workers represents a valuable opportunity to develop more effective, reliable, and well-integrated AI solutions in clinical practice. Our findings emphasize the importance of a bottom-up approach and highlight how adequate training and organizational support can help overcome existing barriers, promoting sustainable and equitable innovation aligned with public health priorities.
AI snapshot
Written from the paper’s full text.
TL;DR
This scoping review synthesized 7 studies (2019–2024) on healthcare workers’ perceived barriers and facilitators to AI implementation in diabetes management, mapped through the CFIR framework. It identifies trust, performance, cost, data security, training, and integration concerns as key barriers, while efficiency, usability, time savings, and organizational support emerge as facilitators.
Key findings
- From 3451 records retrieved, 593 duplicates removed, 3143 titles/abstracts screened, 32 full texts reviewed, and 7 studies included; sample sizes ranged from 10 to 207 participants in the text, with ages 40–60 years.
- Barriers included unsatisfactory clinical performance, high acquisition costs, data security/liability concerns, black-box decision-making, limited training, poor integration with hospital information systems, lack of collaborative networks, fear of job displacement or lost autonomy, insufficient reimbursement, and increased workload.
- Facilitators included improved clinical efficiency, ease of use, time savings for patients and physicians, organizational support, engagement of administrators/department heads, positive attitudes toward AI, perceived care coordination, ease of integration, national guidelines, and a stronger primary doctor filter function.
- Most included studies focused on AI for diabetic retinopathy screening (5 of 7); only two addressed glycemic control or general diagnostic intervention. Designs were 4 qualitative, 2 cross-sectional, and 1 mixed-methods.
Methods
- Scoping review following PRISMA-ScR, registered in OSF, using the PCC framework and searching PubMed Medline, Scopus, CINHAL, and Embase without temporal restrictions, updated to 31 January 2025.
- Two-phase selection (title/abstract then full text) conducted independently by three researchers, with a fourth resolving conflicts; data extraction and quality appraisal used JBI tools and MMAT, with narrative synthesis guided by CFIR and SWiM because meta-analysis was not feasible.
Limitations
- Stated by the paper: the exploratory scoping review design prevented quantitative synthesis due to methodological heterogeneity; many findings rely on subjective perceptions of healthcare workers; future longitudinal and randomized studies are needed to assess real effectiveness and efficiency.
- Evident from the text: only 7 studies were included, most focused on diabetic retinopathy screening rather than broader diabetes management; sample sizes varied widely; quality appraisal rated several studies as low or medium quality, and no studies were excluded for insufficient quality.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
51 of 101 cited sources checked · 32 supported · 0 flagged · accuracy not yet measured
- Study design and conductreasoning
A narrative synthesis was chosen because a combined quantitative synthesis (meta-analysis) was not feasible due to heterogeneity of included studies.
“In this review, while the benefits of meta-analysis are acknowledged, a combined quantitative synthesis was deemed not feasible due to the heterogeneity of the included studies.”
- Also stated in: § 2.7. Synthesis of the Results · plain
“As a result, a detailed narrative synthesis was chosen, following established guidelines for synthesis without meta-analysis (SWiM) [50].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [50] Campbell, 2020, Synthesis without Meta-Analysis (SWiM) in Systematic Reviews: Reporting Guideline, BMJ source
The Abstract describes alternatives to meta-analysis, often called narrative synthesis, and Item 5 discusses methods to use when meta-analysis is not possible. The guideline does not assess the citing review’s included studies or establish that their heterogeneity made meta-analysis infeasible; that review-specific reason is not supported by this source. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Also stated in: § 2.7. Synthesis of the Results · plain
- Findingcitation
Ease of use is a facilitator to AI adoption in diabetes management.
“easiness of use [52,54]”
- Also stated in: § Abstract · plain
“ease of use”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
The Results section, under “Innovation complexity (+): easiness of use,” identifies ease of use as a facilitator of implementing imaging-based diagnostic AI software in hospitals. The paper does not establish this finding specifically for AI adoption in diabetes management; its mention of diabetic retinopathy does not make that the setting of the ease-of-use finding. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [54] Roy, M., Jamwal, M., Vasudeva, S., and Singh, M. (2024). Physicians Behavioural Intentions towards AI-Based Diabetes Diagnostic Interventions in India. J. Public Health. source
- Also stated in: § Abstract · plain
- Findingcitation
Impact of a grading workload is a barrier in the implementation process domain.
“and the impact of a grading workload [57].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [57] Wahlich, 2025, Patient and Practitioner Perceptions around Use of Artificial Intelligence within the English NHS Diabetic Eye Screening Programme, Diabetes Res. Clin. Pract. source
Section 3.1.3 (Impact on the workforce; page unavailable) reports that practitioners expected AI to reduce graders’ workload but worried this could lead to job losses or cuts rather than reinvestment. This supports concern about the impact of changing grading workload, but the paper does not identify grading workload itself as a barrier in an ‘implementation process’ domain. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Findingcitation
Successful active engagement of the clinicians is a facilitator in the implementation process domain.
“The only facilitator identified in the implementation process is the successful active engagement of the clinicians [52].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
- Findingcitation
Improved clinical efficiency is a facilitator to AI adoption in diabetes management.
“The identified facilitators are an improved clinical efficiency [52,54,55]”
- Also stated in: § Abstract · plain
“Key facilitators include improved clinical efficiency”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
The Results table identifies improved clinical efficiency as a facilitator for implementing imaging-based diagnostic AI software, and the Results > Innovation section says participants found the software quicker than human interpretation. The Methods > Innovation selection section shows that diabetic-retinopathy screening was one application studied, but the efficiency finding is not reported specifically for diabetes management. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [54] Roy, M., Jamwal, M., Vasudeva, S., and Singh, M. (2024). Physicians Behavioural Intentions towards AI-Based Diabetes Diagnostic Interventions in India. J. Public Health. source
- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
- Also stated in: § Abstract · plain
- Findingcitation
Diagnostic limitations of AI systems (they may not detect other conditions besides the one for which they have been designed) are a barrier to AI adoption.
“whereas the studies of Wewetzer et al. [56] and Wahlich et al. [57] highlighted diagnostic limitations of AI systems (they may not detect other conditions besides the one for which they have been designed for, leading to incomplete diagnosis).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [56] Wewetzer, 2023, Determinants of the Implementation of Artificial Intelligence-Based Screening for Diabetic Retinopathy-a Cross-Sectional Study with General Practitioners in Germany, Digit. Health source
- cites [57] Wahlich, 2025, Patient and Practitioner Perceptions around Use of Artificial Intelligence within the English NHS Diabetic Eye Screening Programme, Diabetes Res. Clin. Pract. source
- Findingcitation
Concerns about data security are a barrier to AI adoption in diabetes management.
“Another fundamental barrier to consider is the concern about data security, liability, and how the system made the decision (black box problem) [54,55,57].”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [54] Roy, M., Jamwal, M., Vasudeva, S., and Singh, M. (2024). Physicians Behavioural Intentions towards AI-Based Diabetes Diagnostic Interventions in India. J. Public Health. source
- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
- cites [57] Wahlich, 2025, Patient and Practitioner Perceptions around Use of Artificial Intelligence within the English NHS Diabetic Eye Screening Programme, Diabetes Res. Clin. Pract. source
Section 3.1.4 (page unavailable) reports data-security concerns and questions about who is responsible if AI misses disease; section 3.1.1 describes limited understanding of AI as a barrier to acceptance. These findings concern AI in diabetic eye screening, not diabetes management generally, and the copy does not specifically identify difficulty explaining an individual AI decision as a barrier. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Findingcitation
Lack of a collaborative network between primary, secondary, and tertiary hospitals is a barrier in the outer setting domain.
“For the outer setting domain, the crucial emerging barrier is the lack of a collaborative network between primary, secondary, and tertiary hospitals”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [51] Held, 2022, Determinants of the Implementation of an Artificial Intelligence-Supported Device for the Screening of Diabetic Retinopathy in Primary Care—A Qualitative Study, Health Inform. J. source
- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
- Findingcitation
Ease of integration with simple installation is a facilitator in the inner setting domain.
“The only inner setting facilitator identified under this domain is the ease of integration, with the associated simple installation [51,52].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [51] Held, 2022, Determinants of the Implementation of an Artificial Intelligence-Supported Device for the Screening of Diabetic Retinopathy in Primary Care—A Qualitative Study, Health Inform. J. source
- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
In Results > Inner setting, the paper identifies integration with existing hospital systems as a facilitator, and Table 5 says PACS integration reduced workflow interruptions. It does not describe installation as simple. Table 5 also lists regular departmental communication as an inner-setting facilitator, so integration was not the only one. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Findingcitation
Engagement of hospital administrators or department heads is a facilitator in the individuals domain.
“The facilitators belonging to this domain are engagement of hospital administrators or department heads [52]”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
- Findingcitation
Doubts about reliability and accuracy negatively impact physician confidence in the AI system.
“Finally, doubts about reliability and accuracy may negatively impact physician confidence in the system [56,57].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [56] Wewetzer, 2023, Determinants of the Implementation of Artificial Intelligence-Based Screening for Diabetic Retinopathy-a Cross-Sectional Study with General Practitioners in Germany, Digit. Health source
The Results (Table 1) identify examination validity as an important factor in implementing AI screening, and the Discussion reports physicians’ fear that the system could overlook other eye diseases. These passages support concern about accuracy, but the paper does not establish that such doubts reduce physicians’ confidence in the system; its Limitations also caution against causal conclusions. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [57] Wahlich, 2025, Patient and Practitioner Perceptions around Use of Artificial Intelligence within the English NHS Diabetic Eye Screening Programme, Diabetes Res. Clin. Pract. source
Sections 3.1.10 (Accuracy and reliability of AI technology) and 3.1.5 (Trust), with no page numbers available, report healthcare practitioners’ concerns about AI accuracy and reliability and state that AI errors could affect staff confidence. This supports the hedged link to confidence, but the paper discusses screening staff and other healthcare practitioners, not physicians specifically. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Findingcitation
Insufficient reimbursement by health care systems is a barrier in the outer setting domain.
“A study also reported that insufficient reimbursement by health care systems may act as a significant barrier [56].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [56] Wewetzer, 2023, Determinants of the Implementation of Artificial Intelligence-Based Screening for Diabetic Retinopathy-a Cross-Sectional Study with General Practitioners in Germany, Digit. Health source
- Findingcitation
High costs of AI software/acquisition are a barrier to AI adoption in diabetes management.
“Another common barrier is related to the financial burden of AI software/high acquisition costs [52,53,56].”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
- cites [53] Petersen, 2024, How to Improve Attendance for Diabetic Retinopathy Screening: Ideas and Perspectives From People with Type 2 Diabetes and Health-Care Professionals, Can. J. Diabetes source
- cites [56] Wewetzer, 2023, Determinants of the Implementation of Artificial Intelligence-Based Screening for Diabetic Retinopathy-a Cross-Sectional Study with General Practitioners in Germany, Digit. Health source
The Conclusion identifies financial concerns about purchasing, implementing, and maintaining AI-assisted diabetic-retinopathy screening devices as the most relevant barrier reported by the surveyed German GPs. This supports the high-acquisition-cost point, but the paper does not specifically identify AI software costs or establish the same barrier across diabetes management more broadly. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Findingcitation
Perception of AI as a support is a facilitator in the individuals domain.
“or perception of AI as a support [57].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [57] Wahlich, 2025, Patient and Practitioner Perceptions around Use of Artificial Intelligence within the English NHS Diabetic Eye Screening Programme, Diabetes Res. Clin. Pract. source
- Findingcitation
Lack of integration of the AI system into the hospital/facility information system is a barrier in the inner setting domain.
“Also, the lack of integration of the AI system into the hospital/facility information system is another relevant concern that acts as a barrier [54,55,56].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [54] Roy, M., Jamwal, M., Vasudeva, S., and Singh, M. (2024). Physicians Behavioural Intentions towards AI-Based Diabetes Diagnostic Interventions in India. J. Public Health. source
- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
- cites [56] Wewetzer, 2023, Determinants of the Implementation of Artificial Intelligence-Based Screening for Diabetic Retinopathy-a Cross-Sectional Study with General Practitioners in Germany, Digit. Health source
The Results (Technical Implementation, Table 2) rate integration into the practice information system as a relevant factor, and the Discussion calls integration into the practice system a technical concern. The study concerns German general practices, not hospital information systems, and these passages do not classify the concern under an “inner setting” domain. Page numbers are unavailable in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Findingcitation
Perceived unsatisfactory clinical performance of AI systems is a barrier to AI adoption in diabetes management.
“The relevant barrier under this domain is the unsatisfactory clinical performance of the AI system.”
- Also stated in: § Abstract · plain
“The adoption of AI tools in diabetes management is influenced by several barriers, including perceived unsatisfactory clinical performance”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [51] Held, 2022, Determinants of the Implementation of an Artificial Intelligence-Supported Device for the Screening of Diabetic Retinopathy in Primary Care—A Qualitative Study, Health Inform. J. source
- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
The Results (Innovation) identify “unsatisfactory clinical performance” as a barrier and report clinicians’ concerns about accuracy, false positives, and lesion classification. The study concerns imaging-based diagnostic AI in Chinese hospitals, however; it does not establish this barrier specifically for AI adoption in diabetes management. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [53] Petersen, 2024, How to Improve Attendance for Diabetic Retinopathy Screening: Ideas and Perspectives From People with Type 2 Diabetes and Health-Care Professionals, Can. J. Diabetes source
- Also stated in: § Abstract · plain
- Findingcitation
Time-saving is a facilitator to AI adoption in diabetes management.
“the time sparing effect, both for the patient and for the physician [53,56,57]”
- Also stated in: § Abstract · plain
“time-saving”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [53] Petersen, 2024, How to Improve Attendance for Diabetic Retinopathy Screening: Ideas and Perspectives From People with Type 2 Diabetes and Health-Care Professionals, Can. J. Diabetes source
- cites [56] Wewetzer, 2023, Determinants of the Implementation of Artificial Intelligence-Based Screening for Diabetic Retinopathy-a Cross-Sectional Study with General Practitioners in Germany, Digit. Health source
- cites [57] Wahlich, 2025, Patient and Practitioner Perceptions around Use of Artificial Intelligence within the English NHS Diabetic Eye Screening Programme, Diabetes Res. Clin. Pract. source
Section 3.1.8 (Efficiency; page unavailable) reports that patients and healthcare professionals expected AI to speed up diabetic eye screening and free staff for other tasks. Section 3.1.7 (Practicalities of AI implementation; page unavailable) also records a patient's expectation of faster results. These are perceived benefits in eye screening, not demonstrated time savings for both patients and physicians across diabetes management. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Also stated in: § Abstract · plain
- Findingcitation
Incompetence in understanding the AI reasoning mechanisms is a barrier in the individuals domain.
“incompetence in understanding the AI reasoning mechanisms [52]”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
- Findingcitation
Lack of feedback in incorporation of the system is a barrier in the implementation process domain.
“The principal barriers are the lack of feedback in incorporation of the system [52]”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
- Findingcitation
Tensions between GPs and specialists with the concern of a lower referral rate is a barrier in the outer setting domain.
“which includes the related tensions between GPs and specialists with the concern of a lower referral rate [51,52].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [51] Held, 2022, Determinants of the Implementation of an Artificial Intelligence-Supported Device for the Screening of Diabetic Retinopathy in Primary Care—A Qualitative Study, Health Inform. J. source
- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
The Results (Outer setting; page unavailable) identify a lack of collaboration between primary/secondary and tertiary hospitals as a barrier that delays referrals. They do not describe tensions between GPs and specialists or concern about a lower referral rate. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Findingcitation
Positive attitude towards the future of AI technology is a facilitator in the individuals domain.
“positive attitude towards the future of AI technology [57]”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [57] Wahlich, 2025, Patient and Practitioner Perceptions around Use of Artificial Intelligence within the English NHS Diabetic Eye Screening Programme, Diabetes Res. Clin. Pract. source
- Findingcitation
Concerns about decision-making transparency (black box problem) are a barrier to AI adoption in diabetes management.
“Another fundamental barrier to consider is the concern about data security, liability, and how the system made the decision (black box problem) [54,55,57].”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [54] Roy, M., Jamwal, M., Vasudeva, S., and Singh, M. (2024). Physicians Behavioural Intentions towards AI-Based Diabetes Diagnostic Interventions in India. J. Public Health. source
- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
- cites [57] Wahlich, 2025, Patient and Practitioner Perceptions around Use of Artificial Intelligence within the English NHS Diabetic Eye Screening Programme, Diabetes Res. Clin. Pract. source
- Findingcitation
Limited training among healthcare workers is a barrier to AI adoption in diabetes management.
“The principal barrier related to the inner setting is the lack of adequate training or limited knowledge and training on the AI system [52,54,55].”
- Also stated in: § Abstract · plain
“limited training among healthcare workers”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
The Results section, under “Access to knowledge and information,” identifies inadequate training as a barrier to clinicians’ use of AI-assisted software. The study concerns imaging-based diagnostic software in Chinese hospitals, not AI adoption in diabetes management; it also does not establish training as the principal inner-setting barrier. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [54] Roy, M., Jamwal, M., Vasudeva, S., and Singh, M. (2024). Physicians Behavioural Intentions towards AI-Based Diabetes Diagnostic Interventions in India. J. Public Health. source
- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
- Also stated in: § Abstract · plain
- Findingown data
Whalich et al. and Held et al. were rated as medium-quality due to the absence of statements addressing the researchers' cultural positions and the mutual influence between the researchers and the research process.
“Regarding the four qualitative studies, Whalich et al. [57] and Held et al. [51] were rated as medium-quality due to the absence of statements addressing the researchers’ cultural positions and the mutual influence between the researchers and the research process.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [57] Wahlich, 2025, Patient and Practitioner Perceptions around Use of Artificial Intelligence within the English NHS Diabetic Eye Screening Programme, Diabetes Res. Clin. Pract. source
- cites [51] Held, 2022, Determinants of the Implementation of an Artificial Intelligence-Supported Device for the Screening of Diabetic Retinopathy in Primary Care—A Qualitative Study, Health Inform. J. source
- Findingcitation
Development of national guidelines related to AI is a facilitator in the outer setting domain.
“The facilitators reported that can be classified under this domain are the development of national guidelines related to AI [52]”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
- Findingcitation
Most of the included studies focused on the use of AI for diabetic retinopathy screening.
“The majority of the included studies were focused on the use of AI for diabetic retinopathy screening [51,52,53,56,57]”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [51] Held, 2022, Determinants of the Implementation of an Artificial Intelligence-Supported Device for the Screening of Diabetic Retinopathy in Primary Care—A Qualitative Study, Health Inform. J. source
- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
The Methods (Innovation selection) identify diabetic retinopathy screening as one of two AI applications investigated, alongside lung nodule detection. The paper can serve as an example of a study that includes diabetic retinopathy screening, but it does not establish that most studies in the citing document focused on it. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [53] Petersen, 2024, How to Improve Attendance for Diabetic Retinopathy Screening: Ideas and Perspectives From People with Type 2 Diabetes and Health-Care Professionals, Can. J. Diabetes source
- Findingcitation
Most of the included studies adopted a qualitative design (n = 4) that used semi-structured interviews.
“Most of the studies adopted a qualitative design (n = 4) that used semi-structured interviews [51,52,53,57].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [51] Held, 2022, Determinants of the Implementation of an Artificial Intelligence-Supported Device for the Screening of Diabetic Retinopathy in Primary Care—A Qualitative Study, Health Inform. J. source
- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
- cites [53] Petersen, 2024, How to Improve Attendance for Diabetic Retinopathy Screening: Ideas and Perspectives From People with Type 2 Diabetes and Health-Care Professionals, Can. J. Diabetes source
- Interpretationcitation
The cost barrier of acquiring and managing AI can be interpreted in terms of equity in access to healthcare innovations.
“The barrier represented by the costs of acquiring and managing AI can also be interpreted in terms of equity in access to healthcare innovations [65].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [65] Ahmad, 2021, Artificial Intelligence (AI) in Medicine, Current Applications and Future Role with Special Emphasis on Its Potential and Promise in Pathology: Present and Future Impact, Obstacles Including Costs and Acceptance among Pathologists, Practical and Philosophical Considerations. A Comprehensive Review, Diagn. Pathol. source
- Interpretationcitation
Integrating AI into routine clinical practice necessitates parallel transformations in organizational routines, workforce training, and digital competencies among healthcare professionals.
“However, integrating AI into routine clinical practice necessitates parallel transformations in organizational routines, workforce training, and digital competencies among healthcare professionals [98].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [98] Gumus, 2025, Perspectives of Physicians, Nurses, and Patients on the Use of Artificial Intelligence and Robotic Nurses in Healthcare, Int. Nurs. Rev. source
- Findingown data
A total of 7 studies, conducted between 2019 and 2024, were included in the review.
“Finally, a total of n = 7 studies, conducted between 2019 and 2024, were included [51,52,53,54,55,56,57].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [51] Held, 2022, Determinants of the Implementation of an Artificial Intelligence-Supported Device for the Screening of Diabetic Retinopathy in Primary Care—A Qualitative Study, Health Inform. J. source
- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
- cites [53] Petersen, 2024, How to Improve Attendance for Diabetic Retinopathy Screening: Ideas and Perspectives From People with Type 2 Diabetes and Health-Care Professionals, Can. J. Diabetes source
- Interpretationcitation
Barriers and facilitators to AI adoption operate on multiple levels, reflecting organizational, technological, individual, and systemic dynamics.
“The findings of this study, interpreted through the CFIR framework [49], clearly show that the barriers and facilitators to AI adoption operate on multiple levels, reflecting organizational, technological, individual, and systemic dynamics that influence full implementation and value realization.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [49] Damschroder, 2009, Fostering Implementation of Health Services Research Findings into Practice: A Consolidated Framework for Advancing Implementation Science, Implement. Sci. source
- Interpretationcitation
Lack of transparency in AI's decision-making processes undermines the trust of healthcare professionals and patients.
“Furthermore, the lack of transparency in AI’s decision-making processes undermines the trust of healthcare professionals and patients, posing an ethical and regulatory challenge essential for the sustainable development of the technology [60,63].”
Quote in the paperSubstantial claim1 of 2 sources checked - Findingreasoning
Organizational support is a facilitator to AI adoption in diabetes management.
“Key facilitators include improved clinical efficiency, ease of use, time-saving, and organizational support, which contribute to broader acceptance of the technology.”
Quote in the paperSubstantial claim - Findingcitation
Fear of job displacement or changes in clinical autonomy is a barrier in the outer setting domain.
“Also, the fear of job displacement or changes in clinical autonomy is another concern that is reported as a barrier [54].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Roy, M., Jamwal, M., Vasudeva, S., and Singh, M. (2024). Physicians Behavioural Intentions towards AI-Based Diabetes Diagnostic Interventions in India. J. Public Health. source
- Findingcitation
High false positive rate in patient risk classification is a barrier to AI adoption.
“Also, Romero et al. [55] reported as a barrier the high false positive rate in patient risk classification”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
- Findingcitation
Forgetfulness to visit the patient is a barrier in the individuals domain.
“or forgetfulness to visit the patient [53].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Petersen, 2024, How to Improve Attendance for Diabetic Retinopathy Screening: Ideas and Perspectives From People with Type 2 Diabetes and Health-Care Professionals, Can. J. Diabetes source
- Findingcitation
Negative personal attitude towards AI systems is a principal barrier in the individuals domain.
“The principal barrier is the negative personal attitude towards AI systems, with associated skepticism [51]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Held, 2022, Determinants of the Implementation of an Artificial Intelligence-Supported Device for the Screening of Diabetic Retinopathy in Primary Care—A Qualitative Study, Health Inform. J. source
- Findingcitation
Perception of increased care coordination is a facilitator in the individuals domain.
“perception of increased care coordination [55]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
- Findingcitation
Increased workload due to extra steps outside the routine workflow is a barrier in the implementation process domain.
“the increased workload due to extra steps outside the routine workflow [55]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
- Findingown data
Only two included studies focused on AI as a tool for glycemic control and AI as a general tool for diagnostic intervention.
“with only two studies focused on AI as a tool for glycemic control and AI as a general tool for diagnostic intervention [54,55].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [54] Roy, M., Jamwal, M., Vasudeva, S., and Singh, M. (2024). Physicians Behavioural Intentions towards AI-Based Diabetes Diagnostic Interventions in India. J. Public Health. source
- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
- Findingown data
The two cross-sectional studies presented as low-quality due to the lack of information during the description of the inclusion and exclusion criteria and the setting of the study.
“The two studies with a cross-sectional design presented as low-quality due to the lack of information during the description of the inclusion and exclusion criteria [54] and the setting of the study”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Roy, M., Jamwal, M., Vasudeva, S., and Singh, M. (2024). Physicians Behavioural Intentions towards AI-Based Diabetes Diagnostic Interventions in India. J. Public Health. source
- Findingcitation
Strengthening of the primary doctor filter function and an associated closer relationship between patient and GP is a facilitator in the outer setting domain.
“the strengthening of the primary doctor filter function, and an associated closer relationship between patient and GP [51].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Held, 2022, Determinants of the Implementation of an Artificial Intelligence-Supported Device for the Screening of Diabetic Retinopathy in Primary Care—A Qualitative Study, Health Inform. J. source
- Interpretationnone given
The adoption of AI in chronic care, particularly in diabetes management, is shaped by a dynamic interplay of perceived barriers and facilitators among healthcare professionals.
“The adoption of AI in chronic care, particularly in diabetes management, is shaped by a dynamic interplay of perceived barriers and facilitators among healthcare professionals.”
Quote in the paperSubstantial claim - Interpretationreasoning
Poor integration with existing information systems hinders true interoperability.
“Adding to this is the poor integration with existing information systems, which are often not designed to accommodate supplementary technologies, thereby hindering true interoperability.”
Quote in the paperSubstantial claim - Study design and conductreasoning
The exploratory nature of the scoping review did not allow for a quantitative synthesis of data due to methodological heterogeneity of the included studies and cohorts.
“The exploratory nature of the scoping review did not allow for a quantitative synthesis of data due to the methodological heterogeneity of the included studies and the cohorts considered.”
Quote in the paperNot a substantial claim - Premisecitation
Without appropriate regulation and inclusive planning, the risk of exacerbating health inequities remains high, particularly in underserved or digitally marginalized populations.
“However, without appropriate regulation and inclusive planning, the risk of exacerbating health inequities remains high—particularly in underserved or digitally marginalized populations [109,110].”
Quote in the paperSubstantial claim0 of 2 sources checked
- Classified as probably not a substantial claim. 20
- May combine two claims. 12
- The quote only partly states this claim. 3
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims. The quote only partly states this claim.
Study design and conductcitationData extraction and quality appraisal used Joanna Briggs Institute (JBI) tools.
“The risk of bias and methodological quality of the included studies were assessed using established guidelines of the JBI framework [43].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [43] Tricco, 2018, PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation, Ann. Intern. Med. source
The Introduction says JBI published guidance for conducting scoping reviews, and the PRISMA-ScR checklist (Table 1) addresses how to report critical appraisal if it is done. Neither passage establishes that JBI tools were used to assess the included studies; the checklist is a reporting guideline, not a record of that assessment. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationRisk of bias and methodological quality were assessed using JBI checklists for qualitative and cross-sectional studies and the MMAT tool for mixed-methods studies.
“The risk of bias and methodological quality of the included studies were evaluated using JBI checklists for qualitative [45] and cross-sectional studies [46] and the MMAT tool for mixed-methods studies [47].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [45] Lockwood, 2015, Qualitative Research Synthesis: Methodological Guidance for Systematic Reviewers Utilizing Meta-Aggregation, Int. J. Evid.-Based Healthc. source
- cites [46] Aromataris, E., and Munn, Z. (2017). Chapter 7: Systematic Reviews of Etiology and Risk. Joanna Briggs Institute Reviewer’s Manual, The Joanna Briggs Institute.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [47] Hong, 2018, The Mixed Methods Appraisal Tool (MMAT) Version 2018 for Information Professionals and Researchers, EFI source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe scoping review was conducted following PRISMA-ScR guidelines for reporting.
“This review followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews guidelines (PRISMA-ScR) (PRISMA-ScR checklist available in Supplementary Table S1) [43].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [43] Tricco, 2018, PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation, Ann. Intern. Med. source
The quote only partly states this claim.
FindingcitationPoorly tailored reporting of AI systems is a barrier to AI adoption.
“Romero et al. [55] and Liao et al. [52] also reported the poorly tailored reporting of AI systems.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
Classified as probably not a substantial claim.
Study design and conductcitationThe CFIR framework was used to structure the description and synthesis of barriers and facilitators.
“The description of the identified barriers and facilitators is structured according to the Consolidated Framework for Implementation Research (CFIR) [49]”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [49] Damschroder, 2009, Fostering Implementation of Health Services Research Findings into Practice: A Consolidated Framework for Advancing Implementation Science, Implement. Sci. source
May combine two claims.
InterpretationcitationFragmented care coordination and lack of shared governance structures limit the effective deployment of AI across healthcare levels.
“Additionally, fragmented care coordination and lack of shared governance structures were seen as limiting factors in the effective deployment of AI across healthcare levels [101,102].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [101] Nair, 2023, Impact of Holistic, Patient-Centric Yoga & Naturopathy-Based Lifestyle Modification Program in Patients with Musculoskeletal Disorders: A Quasi-Experimental Study, Adv. Integr. Med. source
- cites [102] Baines, 2022, Meaningful Patient and Public Involvement in Digital Health Innovation, Implementation and Evaluation: A Systematic Review, Health Expect. source
The Results and Discussion passages address barriers to patient and public involvement in digital health, including power imbalances and a disconnect between developers and patients. They do not address fragmented care coordination, shared governance across healthcare levels, or AI deployment. Searches for those terms and close paraphrases found no passage supporting the attributed claim; page numbers were unavailable in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationTwo included studies were performed inside community healthcare centers.
“Notably, two studies were performed inside community healthcare centers [52,57].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
- cites [57] Wahlich, 2025, Patient and Practitioner Perceptions around Use of Artificial Intelligence within the English NHS Diabetic Eye Screening Programme, Diabetes Res. Clin. Pract. source
The Subjects, materials and methods section describes an online survey and says validation interviews took place at three diabetic eye screening programme centres. It does not identify those centres as community healthcare centres or say the study itself was performed inside them; searches for community health centres yielded no further passage establishing that setting. (LLM, conf=0.70)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
Study design and conductcitationThe use of the CFIR framework allowed for an in-depth analysis of factors influencing AI adoption by healthcare workers and a coherent classification from a public health perspective.
“The use of the CFIR framework [49] allowed for an in-depth analysis of the factors influencing AI adoption by healthcare workers, facilitating a coherent and useful classification from a public health perspective.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [49] Damschroder, 2009, Fostering Implementation of Health Services Research Findings into Practice: A Consolidated Framework for Advancing Implementation Science, Implement. Sci. source
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationTwo quantitative cross-sectional studies were based on surveys.
“Two quantitative cross-sectional studies were based on surveys [54,56]”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [54] Roy, M., Jamwal, M., Vasudeva, S., and Singh, M. (2024). Physicians Behavioural Intentions towards AI-Based Diabetes Diagnostic Interventions in India. J. Public Health. source
- cites [56] Wewetzer, 2023, Determinants of the Implementation of Artificial Intelligence-Based Screening for Diabetic Retinopathy-a Cross-Sectional Study with General Practitioners in Germany, Digit. Health source
Classified as probably not a substantial claim.
InterpretationcitationThe lack of adequate training on AI tools is a systemic barrier that must be urgently addressed.
“From an internal perspective, the lack of adequate training on AI tools is a systemic barrier that must be urgently addressed—especially if the goal is to adopt AI-based care systems across multiple levels of healthcare delivery [77].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [77] Ahmed, 2023, A Systematic Review of the Barriers to the Implementation of Artificial Intelligence in Healthcare, Cureus source
May combine two claims.
Study design and conductcitationThe study adopted JBI methodology, PRISMA-ScR guidelines, and OSF protocol registration, which ensure transparency and international rigor.
“The study’s strengths include its solid methodological framework, facilitated by the adoption of the JBI methodology, the PRISMA-ScR guidelines for reporting [43,44], and the registration of the protocol on the OSF database, elements that ensure transparency and international rigor.”
Quote in the paperNot a substantial claim1 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
FindingreasoningWewetzer et al. was reported as medium-quality owing to the lack of managing confounding factors.
“while the study by Wewetzer et al. [56] was reported as medium-quality owing to the lack of managing confounding factors.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [56] Wewetzer, 2023, Determinants of the Implementation of Artificial Intelligence-Based Screening for Diabetic Retinopathy-a Cross-Sectional Study with General Practitioners in Germany, Digit. Health source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenLiao et al. and Peterson et al. were well designed.
“The studies by Liao et al. [52] and Peterson et al. [53] were well designed.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [52] Liao, 2024, Barriers and Facilitators to Implementing Imaging-Based Diagnostic Artificial Intelligence-Assisted Decision-Making Software in Hospitals in China: A Qualitative Study Using the Updated Consolidated Framework for Implementation Research, BMJ Open source
- cites [53] Petersen, 2024, How to Improve Attendance for Diabetic Retinopathy Screening: Ideas and Perspectives From People with Type 2 Diabetes and Health-Care Professionals, Can. J. Diabetes source
May combine two claims.
PremisecitationIn chronic disease management, AI systems can support transitions between care settings, enhance remote monitoring, and offer predictive insights that guide therapeutic decisions.
“For chronic disease management, where continuity and coordination of care are essential, AI systems can support transitions between care settings, enhance remote monitoring, and offer predictive insights that guide therapeutic decisions [106,107,108].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [106] Awad, 2021, Connected Healthcare: Improving Patient Care Using Digital Health Technologies, Adv. Drug. Deliv. Rev. source
The Introduction describes remote monitoring and chronic-condition management outside traditional care settings, and §2 (Sensors) says AI can improve interpretations of real-time sensor data. The paper does not establish that AI supports transitions between care settings. Section 5.1 describes predictive analysis for its diabetes-monitoring example as a future possibility, not an existing source of insights guiding treatment decisions. Page numbers were not provided in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [107] Neborachko, 2019, Current Trends of Digital Solutions for Diabetes Management, Diabetes Metab. Syndr. Clin. Res. Rev. source
- cites [108] Yang, 2024, Harnessing the Potential of Artificial Intelligence: Affordances, Constraints, and Strategic Implications for Professional Services, J. Strateg. Inf. Syst. source
- Rests on an assumption: Continuity and coordination of care are essential for chronic disease management.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationOne included study adopted a mixed-methods design.
“and finally, one study adopted a mixed-methods design [55].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe involved healthcare professionals were mainly nurses, healthcare assistants, and doctors.
“The involved healthcare professionals were mainly nurses, healthcare assistants, and doctors (i.e., ophthalmologists, diabetologists, endocrinologists, physicians, and general practitioners).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll included studies described research conducted in primary care settings, except the study conducted by Roy et al., which was conducted in a clinic.
“All the included studies described research conducted in primary care settings, with the exception of the study conducted by Roy et al. [54], which was conducted in a clinic.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Roy, M., Jamwal, M., Vasudeva, S., and Singh, M. (2024). Physicians Behavioural Intentions towards AI-Based Diabetes Diagnostic Interventions in India. J. Public Health. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataThe population of included studies varied from 10 participants to 207, with a range of ages from 40 to 60 years.
“The population varied from 10 participants to 207, with a range of ages from 40 to 60 years.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenRomero et al. mixed-methods study was well designed and conducted, with a high-quality rating.
“Finally, the mixed-methods study performed by Romero et al. [55] all was well designed and conducted, with a high-quality rating.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Wyatt, 2020, A Lesson in Implementation: A Pre-Post Study of Providers’ Experience with Artificial Intelligence-Based Clinical Decision Support, Int. J. Med. Inform. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe review protocol was registered in the Open Science Framework database.
“The protocol for this review was registered in the Open Science Framework database (https://osf.io/xgy2z; accessed on 12 June 2025).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims. The quote only partly states this claim.
Study design and conductown dataStudy selection was conducted in two phases-title/abstract screening and full-text review-independently by three researchers, with a fourth resolving conflicts.
“The study selection process for this review followed a two-phase procedure: an initial screening of titles and abstracts, followed by a detailed evaluation of full-text articles.”
- Also stated in: § 2.4. Study Selection Process · plain
“The initial screening was conducted independently and blind by three authors (G.C., A.M., and M.R.), who evaluated titles and abstracts based on their relevance to the study and in accordance with the predefined inclusion criteria. A fourth independent researcher (A.C.) resolved any disagreements at this stage.”
Quote in the paperNot a substantial claim- Also stated in: § 2.4. Study Selection Process · plain
Classified as probably not a substantial claim.
Study design and conductreasoningNo studies were excluded for insufficient quality due to the exploratory nature of the work.
“However, due to the exploratory nature of the present work, no studies were excluded for insufficient quality.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningHealthcare professionals' proximity to patients and deep understanding of local care pathways position them as crucial actors in fostering responsible innovation.
“Their proximity to patients and deep understanding of local care pathways position them as crucial actors in fostering responsible innovation.”
Quote in the paperNot a substantial claim- Rests on an assumption: Healthcare professionals have proximity to patients and deep understanding of local care pathways.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThese findings point toward the value of a bottom-up approach that prioritizes the perspectives and practical needs of frontline professionals as a promising pathway to support successful implementation of AI in clinical practice.
“Crucially, these findings point toward the value of a bottom-up approach—one that prioritizes the perspectives and practical needs of frontline professionals—as a promising pathway to support the successful implementation of AI in clinical practice.”
Quote in the paperNot a substantial claim- Rests on an assumption: The perspectives and practical needs of frontline professionals are important for successful implementation of AI in clinical practice.
May combine two claims.
InterpretationreasoningLack of coordination between levels of care and communication difficulties among professionals represent critical barriers to AI implementation.
“In terms of governance and shared decision-making, it becomes clear that the lack of coordination between levels of care (e.g., primary care, specialists, hospitals) and potential communication difficulties among professionals represent critical barriers to AI implementation.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductreasoningMany findings are based on subjective perceptions of the involved workers in the included studies, requiring caution in interpreting the data.
“Additionally, many findings are based on subjective perceptions of the involved workers in the studies included, which requires caution in interpreting the collected data and highlights the need for future integration with objective data and evidence-driven research.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningActive and continuous involvement of healthcare professionals represents a key opportunity to develop more effective, reliable, and context-aware AI solutions better integrated into everyday clinical workflows.
“Their active and continuous involvement represents a key opportunity to develop more effective, reliable, and context-aware AI solutions that are better integrated into everyday clinical workflows.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The issue of potential barriers and facilitators perceived by healthcare professionals in the effective implementation of AI-based technologies in routine clinical practice remains largely unexplored.
“Nonetheless, the issue of potential barriers and facilitators perceived by healthcare professionals in the effective implementation of these AI-based technologies in routine clinical practice remains largely unexplored—a gap this study aims to address in a bottom-up view”
The paper relies on this without support.
The barriers and facilitators identified from studies focused mainly on diabetic retinopathy screening generalize to AI implementation in diabetes management more broadly.
“The findings of this study, interpreted through the CFIR framework [49], clearly show that the barriers and facilitators to AI adoption operate on multiple levels, reflecting organizational, technological, individual, and systemic dynamics that influence full implementation and value realization.”
The paper relies on this without support.
Continuity and coordination of care are essential for chronic disease management.
“For chronic disease management, where continuity and coordination of care are essential”
The paper relies on this without support.
Healthcare professionals have proximity to patients and deep understanding of local care pathways.
“Their proximity to patients and deep understanding of local care pathways”
The paper relies on this without support.
The perspectives and practical needs of frontline professionals are important for successful implementation of AI in clinical practice.
“one that prioritizes the perspectives and practical needs of frontline professionals—as a promising pathway to support the successful implementation of AI in clinical practice.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Record count after duplicate removal does not add up
MajorRemoving 593 duplicates from 3451 records leaves 2858, not the reported 3143 records screened.
Reported 3143 · recomputed 2858
“A total of n = 3451 records were retrieved from the databases, and after carefully removing the duplicates (n = 593), the researchers (GC, AM, AC, and MR) screened a total of n = 3143 for title and abstract.”
Hospital study contradicts primary-care setting claim
MinorThe text says Roy et al. was the only study outside primary care, but Table 2 lists Petersen et al. as conducted in a hospital.
“All the included studies described research conducted in primary care settings, with the exception of the study conducted by Roy et al. [54], which was conducted in a clinic.”
“| Petersen et al., 2024 [53] | Denmark | Qualitative | Hospital | 18 (61) | AI-assisted system for diabetic retinopathy screening |”
Female percentage column contains a value above 100%
MinorTable 2 labels the parenthetical figure as percent female, but reports 107 for a sample of 209. If 107 is the number of female participants, the percentage is approximately 51.2%, not 107%.
Reported 107 · recomputed 51.196172
“| Wewetzer et al., 2023 [56] | Germany | Cross-sectional | Primary care | 209 (107) | AI-assisted system for diabetic retinopathy screening |”
Cross-sectional studies receive conflicting quality ratings
MinorThe text calls both cross-sectional studies low-quality, then rates one of them, Wewetzer et al., medium-quality.
“The two studies with a cross-sectional design presented as low-quality”
“the study by Wewetzer et al. [56] was reported as medium-quality”
Reported sample-size range excludes a listed study
MinorThe stated maximum sample size is 207, but Table 2 lists 209 participants for Wewetzer et al.
“The population varied from 10 participants to 207”
“| Wewetzer et al., 2023 [56] | Germany | Cross-sectional | Primary care | 209 (107) | AI-assisted system for diabetic retinopathy screening |”
Cites
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565 · see citing works
Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009) · Implementation Science · doi:10.1186/1748-5908-4-50 · Cited by 14,496 · cited 6× · see citing works
“The description of the identified barriers and facilitators is structured according to the Consolidated Framework for Implementation Research (CFIR) [49], a comprehensive theoretical framework widely used to guide implementation research.”
InfluentialSaeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792 · see citing works
The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers
Hong, Q. N., Fàbregues, S., Bartlett, G., Boardman, F., Cargo, M., Dagenais, P., Gagnon, M.-P., Griffiths, F., Nicolau, B., O’Cathain, A., et al. (2018) · Education for Information · doi:10.3233/efi-180221 · Cited by 4,737 · cited 1× · see citing works
“The risk of bias and methodological quality of the included studies were evaluated using JBI checklists for qualitative [45] and cross-sectional studies [46] and the MMAT tool for mixed-methods studies [47].”
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
Campbell, M., McKenzie, J. E., Sowden, A., Katikireddi, S. V., Brennan, S. E., Ellis, S., Hartmann-Boyce, J., Ryan, R., Shepperd, S., Thomas, J., et al. (2020) · BMJ · doi:10.1136/bmj.l6890 · Cited by 4,628 · cited 1× · see citing works
“As a result, a detailed narrative synthesis was chosen, following established guidelines for synthesis without meta-analysis (SWiM) [50].”
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
Alowais, S. A., Alghamdi, S. S., Alsuhebany, N., Alqahtani, T., Alshaya, A. I., Almohareb, S. N., Aldairem, A., Alrashed, M., Bin Saleh, K., Badreldin, H. A., et al. (2023) · BMC Medical Education · doi:10.1186/s12909-023-04698-z · Cited by 3,146 · cited 1× · see citing works
“Time savings, increased clinical efficiency, the perception of greater care coordination and positive acceptance by some operators are valuable elements for the success of public policies that aim at the equitable and sustainable digitalization of healthcare [80–82].”
Greenhalgh, T., Wherton, J., Papoutsi, C., Lynch, J., Hughes, G., A'Court, C., Hinder, S., Fahy, N., Procter, R., & Shaw, S. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.8775 · Cited by 2,887 · cited 1× · see citing works
“According to Greenhalgh et al. (2017), the adoption of new technologies requires a co-construction of change, in which professionals are actively involved not only in the use but also in the design and evaluation of the tools to be implemented in clinical practice [76].”
Lockwood, C., Munn, Z., & Porritt, K. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000062 · Cited by 2,456 · see citing works
Recommendations for the Extraction, Analysis, and Presentation of Results in Scoping Reviews
Pollock, D., Peters, M. D. J., Khalil, H., McInerney, P., Alexander, L., Tricco, A. C., Evans, C., de Moraes, É. B., Godfrey, C. M., Pieper, D., et al. (2023) · JBI Evidence Synthesis · doi:10.11124/jbies-22-00123 · Cited by 1,975 · cited 5× · see citing works
“Data extraction from the included studies was organized into key categories, consistent with the methodological framework [43,44].”
InfluentialChapter 7: Systematic reviews of etiology and risk
Moola, S., Munn, Z., Tufanaru, C., et al. (2020) · JBI eBooks · doi:10.46658/jbimes-20-08 · Cited by 1,351 · cited 1× · see citing works
“The risk of bias and methodological quality of the included studies were evaluated using JBI checklists for qualitative [45] and cross-sectional studies [46] and the MMAT tool for mixed-methods studies [47].”
The United Nations Sustainable Development Goals
Ferranti, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22063-5 · Cited by 753 · see citing works
Transparency and explainability of AI systems: From ethical guidelines to requirements
Balasubramaniam, N., Kauppinen, M., Rannisto, A., Hiekkanen, K., & Kujala, S. (2023) · Information and Software Technology · doi:10.1016/j.infsof.2023.107197 · Cited by 410 · cited 2× · see citing works
“If AI systems are unable to ensure adequate levels of sensitivity and specificity—or if their reliability is perceived as uncertain—they risk undermining the quality of care and increasing the chances of missed or inappropriate diagnoses [60].”
Connected healthcare: Improving patient care using digital health technologies
Awad, A., Trenfield, S. J., Pollard, T. D., Ong, J. J., Elbadawi, M., McCoubrey, L. E., Goyanes, A., Gaisford, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113958 · Cited by 405 · cited 1× · see citing works
“For chronic disease management, where continuity and coordination of care are essential, AI systems can support transitions between care settings, enhance remote monitoring, and offer predictive insights that guide therapeutic decisions [106–108].”
A Systematic Review of the Barriers to the Implementation of Artificial Intelligence in Healthcare
Ahmed, M. I., Spooner, B., Isherwood, J., Lane, M., Orrock, E., & Dennison, A. (2023) · Cureus · doi:10.7759/cureus.46454 · Cited by 364 · cited 1× · see citing works
“From an internal perspective, the lack of adequate training on AI tools is a systemic barrier that must be urgently addressed—especially if the goal is to adopt AI-based care systems across multiple levels of healthcare delivery [77].”
Precision medicine in the era of artificial intelligence: implications in chronic disease management
Subramanian, M., Wojtusciszyn, A., Favre, L., Boughorbel, S., Shan, J., Letaief, K. B., Pitteloud, N., & Chouchane, L. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02658-5 · Cited by 362 · cited 1× · see citing works
“Chronic conditions such as diabetes, hypertension, cardiovascular, and respiratory diseases represent a substantial burden for public healthcare systems and require coordinated, continuous, and patient-centered management strategies [90,91].”
FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine
Warraich, H. J., Tazbaz, T., & Califf, R. M. (2025) · JAMA · doi:10.1001/jama.2024.21451 · Cited by 332 · cited 1× · see citing works
“However, without appropriate regulation and inclusive planning, the risk of exacerbating health inequities remains high—particularly in underserved or digitally marginalized populations [109,110].”
Worldwide AI ethics: A review of 200 guidelines and recommendations for AI governance
Corrêa, N., Galvão, C., Santos, J., del Pino, C., Pinto, E. P., Barbosa, C., Massmann, D., Mambrini, R., Galvão, L., Terem, E., et al. (2022) · Patterns · doi:10.1016/j.patter.2023.100857 · Cited by 330 · see citing works
Barriers to and facilitators of artificial intelligence adoption in health care: scoping review
Hassan, M., Kushniruk, A., & Borycki, E. (2024) · JMIR Human Factors · doi:10.2196/48633 · Cited by 324 · cited 1× · see citing works
“The concern, particularly regarding the potential loss of clinical autonomy—clearly emerging from the data reviewed—is a key issue for the “social” legitimacy of digital innovations in health-care [74,75].”
Ahmad, Z., Rahim, S., Zubair, M., & Abdul-Ghafar, J. (2021) · Diagnostic Pathology · doi:10.1186/s13000-021-01085-4 · Cited by 293 · cited 1× · see citing works
“The barrier represented by the costs of acquiring and managing AI can also be interpreted in terms of equity in access to healthcare innovations [65].”
Chen, Z., Khandpur, N., Desjardins, C., Wang, L., Monteiro, C. A., Rossato, S. L., Fung, T. T., Manson, J. E., Willett, W. C., Rimm, E. B., et al. (2023) · Diabetes Care · doi:10.2337/dc22-1993 · Cited by 275 · see citing works
Protective Factors and the Pathogenesis of Complications in Diabetes
Yu, M. G., Gordin, D., Fu, J., Park, K., Li, Q., & King, G. L. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad030 · Cited by 238 · see citing works
Artificial Intelligence Applications in Health Care Practice: Scoping Review
Sharma, M., Savage, C., Nair, M., Larsson, I., Svedberg, P., & Nygren, J. M. (2022) · Journal of Medical Internet Research · doi:10.2196/40238 · Cited by 198 · cited 1× · see citing works
“The concern, particularly regarding the potential loss of clinical autonomy—clearly emerging from the data reviewed—is a key issue for the “social” legitimacy of digital innovations in health-care [74,75].”
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis
Jancev, M., Vissers, T. A. C. M., Visseren, F. L. J., van Bon, A. C., Serné, E. H., DeVries, J. H., de Valk, H. W., & van Sloten, T. T. (2024) · Diabetologia · doi:10.1007/s00125-024-06107-6 · Cited by 191 · see citing works
Rajesh, A. E., Davidson, O. Q., Lee, C. S., & Lee, A. (2023) · Diabetes Care · doi:10.2337/dci23-0032 · Cited by 166 · see citing works
Witkowski, K. G. K., Okhai, R., & Neely, S. R. (2024) · BMC Medical Ethics · doi:10.1186/s12910-024-01066-4 · Cited by 165 · see citing works
(2023) · doi:10.1002/14651858.cd013775.pub2 · Cited by 145 · see citing works
Romero-Brufau, S., Wyatt, K. D., Boyum, P., Mickelson, M., Moore, M., & Cognetta-Rieke, C. (2020) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.104072 · Cited by 143 · see citing works
Baines, R., Bradwell, H., Edwards, K., Stevens, S., Prime, S., Tredinnick‐Rowe, J., Sibley, M., & Chatterjee, A. (2022) · Health Expectations · doi:10.1111/hex.13506 · Cited by 138 · cited 1× · see citing works
“Additionally, fragmented care coordination and lack of shared governance structures were seen as limiting factors in the effective deployment of AI across healthcare levels [101,102].”
Aravazhi, P. S., Gunasekaran, P., Benjamin, N. Z. Y., Thai, A., Chandrasekar, K. K., Kolanu, N. D., Prajjwal, P., Tekuru, Y., Villacreses-Brito, L. C., & Inban, P. (2025) · Disease-a-Month · doi:10.1016/j.disamonth.2025.101882 · Cited by 131 · cited 1× · see citing works
“Time savings, increased clinical efficiency, the perception of greater care coordination and positive acceptance by some operators are valuable elements for the success of public policies that aim at the equitable and sustainable digitalization of healthcare [80–82].”
The impact of nutrition and lifestyle modification on health
Santos, L. D. C. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.09.020 · Cited by 122 · see citing works
The International Diabetes Federation’s guide for diabetes epidemiological studies
Aschner, P. J., Karuranga, S., James, S., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108630 · Cited by 114 · cited 1× · see citing works
“Projections for 2050 indicate a substantial increase in global prevalence, expected to reach 853 million cases within the same age range, which will likely be accompanied by a corresponding rise in healthcare costs [1–5].”
The impact of technological advancement on culture and society
Alsaleh, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-83995-z · Cited by 108 · cited 1× · see citing works
“To prevent such disparities, healthcare professionals must be empowered not only as end users but also as digital mediators and educators, helping to guide patients and caregivers in the effective and ethical use of AI technologies [111–115].”
Fatoum, H. A., Hanna, S., Halamka, J. D., Sicker, D., Spangenberg, P., & Hashmi, S. K. (2021) · Journal of Medical Internet Research · doi:10.2196/19846 · Cited by 99 · cited 1× · see citing works
“This shift is necessary to ensure that data-driven medicine evolves in a fair, sustainable, and inclusive direction [116,117].”
Ferreira, R. O. M., Trevisan, T., Pasqualotto, E., Chavez, M. P., Marques, B. F., Lamounier, R. N., & van de Sande-Lee, S. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0390 · Cited by 92 · see citing works
Pearson‐Stuttard, J., Holloway, S., Polya, R., Sloan, R., Zhang, L., Gregg, E. W., Harrison, K., Elvidge, J., Jonsson, P. F., & Porter, T. R. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101584 · Cited by 87 · see citing works
Evolution of artificial intelligence in healthcare: a 30-year bibliometric study
Xie, Y., Zhai, Y., & Lu, G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1505692 · Cited by 87 · cited 1× · see citing works
“This shift is necessary to ensure that data-driven medicine evolves in a fair, sustainable, and inclusive direction [116,117].”
Diabetes-Associated Comorbidities
Teck, J. (2022) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2021.11.004 · Cited by 86 · see citing works
Nursing Students’ Perceptions and Use of Generative Artificial Intelligence in Nursing Education
Han, S., Kang, H. S., Gimber, P., & Lim, S. (2025) · Nursing Reports · doi:10.3390/nursrep15020068 · Cited by 86 · cited 1× · see citing works
“This ensures they do not become mere executors but rather informed actors who use technology as an extension of their clinical skill expertise [78,79].”
Kiran, M., Xie, Y., Anjum, N., Ball, G., Pierscionek, B. K., & Russell, D. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1557467 · Cited by 81 · cited 2× · see citing works
“Applications of AI in diabetes care range from early diagnosis to automated insulin dosing management and the identification of critical glycemic patterns, thereby contributing to the emergence of a new paradigm in precision medicine for diabetes [35–41].”
Chen, X., Zhang, L., & Chen, W. (2025) · BMC Medicine · doi:10.1186/s12916-025-03890-w · Cited by 73 · see citing works
Singareddy, S., Vijay Prabhu, S. N., Jaramillo, A. P., Yasir, M. B., Iyer, N., Hussein, S., & Nath, T. S. (2023) · Cureus · doi:10.7759/cureus.46066 · Cited by 67 · cited 1× · see citing works
“This reframing can help overcome cultural resistance to adoption, often rooted in concerns about professional identity and loss of autonomy [99,100].”
Khokhar, P. B., Gravino, C., & Palomba, F. (2024) · Artif. Intell. Medicine · doi:10.1016/j.artmed.2025.103132 · Cited by 63 · cited 2× · see citing works
“Applications of AI in diabetes care range from early diagnosis to automated insulin dosing management and the identification of critical glycemic patterns, thereby contributing to the emergence of a new paradigm in precision medicine for diabetes [35–41].”
IoT-enabled biosensors for real-time monitoring and early detection of chronic diseases
Hossain, M. N., Kwak, Y.-S., Lee, J. E., Choi, H.-S., Park, J. P., & Kim, J. H. (2024) · Physical Activity and Nutrition · doi:10.20463/pan.2024.0033 · Cited by 62 · see citing works
Aljawarneh, Y. M., Wardell, D. W., Wood, G. L., & Rozmus, C. (2019) · Journal of Nursing Scholarship · doi:10.1111/jnu.12472 · Cited by 60 · cited 1× · see citing works
“Emphasis should be placed on balanced nutritional intake, caloric moderation, and the adoption of regular physical activity, with the goal of reducing the global burden of disease and improving population health outcomes in T1D and T2D [27–30].”
Gundlack, J., Thiel, C., Negash, S., Buch, C., Apfelbacher, T., Denny, K., Christoph, J., Mikolajczyk, R., Unverzagt, S., & Frese, T. (2025) · Journal of Medical Internet Research · doi:10.2196/70487 · Cited by 60 · see citing works
Yang, J., Amrollahi, A., & Marrone, M. (2024) · The Journal of Strategic Information Systems · doi:10.1016/j.jsis.2024.101864 · Cited by 59 · cited 1× · see citing works
“For chronic disease management, where continuity and coordination of care are essential, AI systems can support transitions between care settings, enhance remote monitoring, and offer predictive insights that guide therapeutic decisions [106–108].”
Pan, M., Li, R., Wei, J., Peng, H., Hu, Z., Xiong, Y., Li, N., Guo, Y., Gu, W., & Liu, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1506641 · Cited by 56 · see citing works
Kanbour, S., Ageeb, R. A., Malik, R. A., & Abu-Raddad, L. J. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00346-2 · Cited by 55 · see citing works
Collaborative Governance for Integrated Care: Insights from a Policy Stakeholder Dialogue
Gordon, D., McKay, S. M., Marchildon, G. P., et al. (2020) · International Journal of Integrated Care · doi:10.5334/ijic.4684 · Cited by 53 · cited 1× · see citing works
“This issue is part of a broader challenge in healthcare governance, which calls for dynamic and modern models of both vertical and horizontal service integration [71–73].”
Walker, D. M., Tarver, W. L., Jonnalagadda, P., Ranbom, L., Ford, E. W., & Rahurkar, S. (2023) · JMIR Medical Informatics · doi:10.2196/43848 · Cited by 52 · cited 1× · see citing works
“Without full connectivity between AI, electronic health records, and healthcare management systems, AI risks remaining an isolated technology, incapable of delivering real value to patient care [68,69].”
Liao, X., Yao, C., Jin, F., Zhang, J., & Liu, L. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-084398 · Cited by 50 · cited 9× · see citing works
“The identified facilitators are an improved clinical efficiency [52,54,55], easiness of use [52,54], and the time sparing effect, both for the patient and for the physician [53,56,57].”
InfluentialUsman, T. M., Saheed, Y. K., Nsang, A. S., Ajibesin, A., & Rakshit, S. (2023) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2023.102617 · Cited by 49 · see citing works
Senot, C., Chandrasekaran, A., & Ward, P. T. (2015) · Production and Operations Management · doi:10.1111/poms.12404 · Cited by 47 · cited 1× · see citing works
“…by healthcare professionals in the effective implementation of these AI-based technologies in routine clinical practice remains largely unexplored—a gap this study aims to address in a bottom-up view, defined as “an approach guided by healthcare workers’ insights and daily experiences” [42].”
Uwimana, A., Gnecco, G., & Riccaboni, M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109391 · Cited by 46 · see citing works
Nguyen, P. K., Le, L. K., Ananthapavan, J., Gao, L., Dunstan, D. W., & Moodie, M. (2022) · Preventive Medicine · doi:10.1016/j.ypmed.2022.106964 · Cited by 44 · cited 1× · see citing works
“Projections for 2050 indicate a substantial increase in global prevalence, expected to reach 853 million cases within the same age range, which will likely be accompanied by a corresponding rise in healthcare costs [1–5].”
Simulation as a Tool for Clinical Remediation: An Integrative Review
Camp, S., & Legge, T. (2017) · Clinical Simulation in Nursing · doi:10.1016/j.ecns.2017.11.003 · Cited by 43 · cited 1× · see citing works
“…of the items present; thus, a score lower than 70% was classified as low-quality, between 70 and 79% of the checklist criteria was classified as medium–high-quality, between 80 and 90% was assigned high-quality, and a score greater than 90% of the criteria was classified as excellent-quality [48].”
Top 10 public health challenges to track in 2023: Shifting focus beyond a global pandemic
Lucero‐Prisno, D. E., Shomuyiwa, D. O., Kouwenhoven, M. B. N., et al. (2023) · Public Health Challenges · doi:10.1002/puh2.86 · Cited by 42 · see citing works
Artificial Intelligence in the Management of Malnutrition in Cancer Patients: A Systematic Review
Sguanci, M. E., Palomares, S. M., Cangelosi, G., Petrelli, F., Sandri, E., Ferrara, G., & Mancin, S. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100438 · Cited by 42 · see citing works
Self-citationArtificial intelligence tool development: what clinicians need to know?
Chew, B.-H., & Ngiam, K. Y. (2025) · BMC Medicine · doi:10.1186/s12916-025-04076-0 · Cited by 41 · cited 1× · see citing works
“This ensures they do not become mere executors but rather informed actors who use technology as an extension of their clinical skill expertise [78,79].”
Wienert, J., & Zeeb, H. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.610237 · Cited by 38 · cited 1× · see citing works
“…a structured and theory-informed classification of the data, while the discussion reframed these results in light of a bottom-up perspective—that is, how professionals working within healthcare systems perceive, experience, and respond to the integration of AI in their clinical practice [49,93,94].”
Yang, Q., Bee, Y. M., Lim, C. C., Sabanayagam, C., Yim-Lui Cheung, C., Wong, T. Y., Ting, D. S. W., Lim, L.-L., Li, H., He, M., et al. (2025) · eClinicalMedicine · doi:10.1016/j.eclinm.2025.103089 · Cited by 38 · see citing works
Current trends of digital solutions for diabetes management
Neborachko, M., Pkhakadze, A., & Vlasenko, I. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2018.07.014 · Cited by 36 · see citing works
Held, L. A., Wewetzer, L., & Steinhäuser, J. (2022) · Health Informatics Journal · doi:10.1177/14604582221112816 · Cited by 34 · cited 9× · see citing works
“The only inner setting facilitator identified under this domain is the ease of integration, with the associated simple installation [51,52].”
InfluentialAI Governance: A Challenge for Public Health
Wagner, J. K., Doerr, M. J., & Schmit, C. D. (2024) · JMIR Public Health and Surveillance · doi:10.2196/58358 · Cited by 32 · cited 1× · see citing works
“This issue is part of a broader challenge in healthcare governance, which calls for dynamic and modern models of both vertical and horizontal service integration [71–73].”
Faijue, D. D., Segui, A. O., Shringarpure, K. S., et al. (2024) · European Journal of Public Health · doi:10.1093/eurpub/ckae124 · Cited by 30 · see citing works
Henney, A. E., Gillespie, C. S., Alam, U., Hydes, T., Boyland, E. J., & Cuthbertson, D. J. (2024) · Obesity Reviews · doi:10.1111/obr.13682 · Cited by 29 · cited 1× · see citing works
“In particular, dietary patterns characterized by excessive caloric intake, a high consumption of refined grains in place of whole grains, and insufficient physical activity constitute the principal modifiable risk factors [18–20].”
Sguanci, M. E., Mancin, S., Gazzelloni, A., Diamanti, O., Ferrara, G., Palomares, S. M., Parozzi, M., Petrelli, F., & Cangelosi, G. (2024) · Healthcare · doi:10.3390/healthcare13010023 · Cited by 29 · see citing works
Self-citationTop 10 Public Health Challenges for 2024: Charting a New Direction for Global Health Security
Lucero‐Prisno, D. E., Shomuyiwa, D. O., Kouwenhoven, M. B. N., Dorji, T., Adebisi, Y. A., Odey, G. O., George, N. S., Temidayo, A. O., Ekerin, O., Manirambona, E., et al. (2024) · Public Health Challenges · doi:10.1002/puh2.70022 · Cited by 27 · see citing works
Gundlack, J., Negash, S., Thiel, C., Buch, C., Schildmann, J., Unverzagt, S., Mikolajczyk, R., & Frese, T. (2025) · Health Expectations · doi:10.1111/hex.70216 · Cited by 27 · see citing works
Rodrigues, I. B., Fahim, C., Garad, Y., Presseau, J., Hoens, A. M., Braimoh, J., Duncan, D., Bruyn-Martin, L., & Straus, S. E. (2023) · BMC Medical Research Methodology · doi:10.1186/s12874-023-02083-4 · Cited by 25 · cited 1× · see citing works
“…a structured and theory-informed classification of the data, while the discussion reframed these results in light of a bottom-up perspective—that is, how professionals working within healthcare systems perceive, experience, and respond to the integration of AI in their clinical practice [49,93,94].”
Dai, W., & Albrecht, S. S. (2024) · Diabetes Care · doi:10.2337/dc24-0673 · Cited by 25 · cited 1× · see citing works
“In particular, dietary patterns characterized by excessive caloric intake, a high consumption of refined grains in place of whole grains, and insufficient physical activity constitute the principal modifiable risk factors [18–20].”
Gumus, E., & Alan, H. (2025) · International Nursing Review · doi:10.1111/inr.70017 · Cited by 25 · cited 1× · see citing works
“However, integrating AI into routine clinical practice necessitates parallel transformations in organizational routines, workforce training, and digital competencies among healthcare professionals [98].”
Scuri, S., Tesauro, M., Petrelli, F., Argento, N., Damasco, G., Cangelosi, G., Nguyen, C. T. T., Savva, D., & Grappasonni, I. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116805 · Cited by 23 · see citing works
Self-citationShao, H., Shi, L., Lin, Y., & Fonseca, V. A. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108316 · Cited by 23 · cited 1× · see citing works
“In this context, AI can serve as a catalyst for innovation, provided that it is embedded in a well-structured and responsive clinical and organizational ecosystem [92].”
Wewetzer, L., Held, L. A., Goetz, K., & Steinhäuser, J. (2023) · DIGITAL HEALTH · doi:10.1177/20552076231176644 · Cited by 23 · cited 9× · see citing works
“The identified facilitators are an improved clinical efficiency [52,54,55], easiness of use [52,54], and the time sparing effect, both for the patient and for the physician [53,56,57].”
InfluentialThe Impact and Role of Artificial Intelligence (AI) in Healthcare: Systematic Review
Singh, K., Prabhu, A. A., & Kaur, N. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266339394250225112747 · Cited by 23 · see citing works
Wang, Y., Cao, P., Liu, F., Chen, Y., Xie, J., Bai, B., Liu, Q., Ma, H., & Geng, Q. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416412 · Cited by 21 · cited 1× · see citing works
“While genetic predisposition and advancing age are recognized contributors to the pathogenesis of numerous chronic diseases such as diabetes [11,12], it is predominantly unhealthy lifestyle behaviors that significantly influence both the onset and progression of these conditions [13–17].”
Scanzera, A. C., Beversluis, C., Potharazu, A. V., Bai, P., Leifer, A., Cole, E. D., Du, D. Y., Musick, H., & Chan, R. V. P. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1198228 · Cited by 21 · cited 1× · see citing works
“From a practical standpoint, AI-based systems—such as those used for diabetic retinopathy screening or cardiovascular risk stratification [95,96]—can support the early detection of complications, thereby reducing the need for hospital-based interventions and enabling more timely, preventive care.”
Jiang, Y., Hu, J., Chen, F., Liu, B., Wei, M., Xia, W., Yan, Y., Xie, J., Du, S., Tian, X., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101553 · Cited by 21 · cited 1× · see citing works
“While genetic predisposition and advancing age are recognized contributors to the pathogenesis of numerous chronic diseases such as diabetes [11,12], it is predominantly unhealthy lifestyle behaviors that significantly influence both the onset and progression of these conditions [13–17].”
Ethical framework for responsible foundational models in medical imaging
Jha, D., Durak, G., Das, A., Sanjotra, J., Susladkar, O., Sarkar, S., Rauniyar, A., Kumar Tomar, N., Peng, L., Li, S., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1544501 · Cited by 21 · cited 1× · see citing works
“Furthermore, the lack of transparency in AI’s decision-making processes undermines the trust of healthcare professionals and patients, posing an ethical and regulatory challenge essential for the sustainable development of the technology [60,63].”
Hasan, S. U., & Siddiqui, M. A. R. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110943 · Cited by 20 · cited 1× · see citing works
“This confirms what has already been observed in international studies, which emphasize the need for rigorous clinical validation before the large-scale deployment of AI systems [61,62].”
Cangelosi, G., Grappasonni, I., Nguyen, C. T. T., et al. (2023) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v94is3.14406 · Cited by 20 · cited 1× · see citing works
“In light of this evidence, the implementation of comprehensive primary and secondary prevention strategies aimed at promoting healthier lifestyles is imperative [24–26].”
Self-citationCardiorespiratory Fitness and Physical Activity in Pediatric Diabetes
Visser, H. S. D., Fast, I. D., Brunton, N. M., Arevalo, E., Askin, N., Rabbani, R., Abou-Setta, A. M., & McGavock, J. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.0235 · Cited by 20 · see citing works
Pantanetti, P., Cangelosi, G., Palomares, S. M., Ferrara, G., Biondini, F., Mancin, S., Caggianelli, G., Parozzi, M., Sguanci, M. E., & Petrelli, F. (2025) · Diabetology · doi:10.3390/diabetology6010007 · Cited by 18 · cited 1× · see citing works
“The introduction of AI and other technological tools into clinical settings—particularly for the management of chronic diseases—represents a significant opportunity to rethink traditional models of care and transition toward a more predictive, proactive, and personalized approach [84–89].”
Self-citationSguanci, M., Mancin, S., Gazzelloni, A., et al. (2024) · doi:10.20944/preprints202411.0710.v1 · Cited by 18
Self-citationAlkaf, B., Blakemore, A. I. F., Järvelin, M., & Lessan, N. G. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00764-y · Cited by 16 · cited 1× · see citing works
“The majority of individuals with diabetes are obese and physically inactive, particularly within the 45–64 age group (28.9% of males and 32.8% of females) [6–8].”
InfluentialMethodology for Safe and Secure AI in Diabetes Management
Foppen, R. J. G., Gioia, V. L., Gupta, S., Johnson, C. L., Giantsidis, J., & Papademetris, M. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241304434 · Cited by 16 · see citing works
Mannoubi, C., Kairy, D., Menezes, K. V. R. S., Desroches, S., Layani, G., & Vachon, B. (2023) · JMIR Medical Informatics · doi:10.2196/46699 · Cited by 15 · cited 1× · see citing works
“In the context of T2D as well, digital technologies—including self-management applications and telemonitoring tools—are proving valuable, particularly in the personalization of therapeutic interventions and the optimization of clinical outcomes and complication management [31–34].”
Wong, A., Berenbrok, L., Snader, L., Soh, Y. H., Kumar, V., Javed, M., Bates, D., Sorce, L., & Kane-Gill, S. (2023) · Critical Care Explorations · doi:10.1097/cce.0000000000000967 · Cited by 13 · cited 1× · see citing works
“Professionals also reported a willingness to engage with new tools in general technology devices when training is adequate and when they are actively involved in implementation decisions in clinical and social decision [103–105].”
Wahlich, C., Chandrasekaran, L., Chaudhry, U. A. R., Willis, K., Chambers, R., Bolter, L., Anderson, J., Shakespeare, R., Olvera-Barrios, A., Fajtl, J., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111964 · Cited by 13 · cited 9× · see citing works
“The identified facilitators are an improved clinical efficiency [52,54,55], easiness of use [52,54], and the time sparing effect, both for the patient and for the physician [53,56,57].”
InfluentialPhysicians behavioural intentions towards AI-based diabetes diagnostic interventions in India
Roy, M., Jamwal, M., Vasudeva, S., & Singh, M. (2025) · Journal of Public Health · doi:10.1007/s10389-024-02235-w · Cited by 12 · cited 9× · see citing works
“The identified facilitators are an improved clinical efficiency [52,54,55], easiness of use [52,54], and the time sparing effect, both for the patient and for the physician [53,56,57].”
InfluentialAmerkamp, J., Benli, S., Isenmann, E., & Brinkmann, C. K. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.09.016 · Cited by 12 · cited 1× · see citing works
“Emphasis should be placed on balanced nutritional intake, caloric moderation, and the adoption of regular physical activity, with the goal of reducing the global burden of disease and improving population health outcomes in T1D and T2D [27–30].”
Cost-equivalence and Pluralism in Publicly-funded Health-care Systems
Wilkinson, D. J. C., & Savulescu, J. (2017) · Health Care Analysis · doi:10.1007/s10728-016-0337-z · Cited by 10 · cited 1× · see citing works
“Mainly in publicly funded universal healthcare systems, the adoption of expensive technologies risks creating territorial inequalities, where larger or better-funded facilities can afford to implement AI, while peripheral or resource-limited ones risk being effectively excluded [66].”
Yismaw, M. B., Tafere, C., Tefera, B. B., Demsie, D. G., Feyisa, K., Addisu, Z. D., Zeleke, T. K., Siraj, E. A., Worku, M. C., & Berihun, F. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.105858 · Cited by 10 · cited 1× · see citing works
“Predictive models based on AI techniques such as machine learning (ML) and deep learning (DL) are being developed and implemented to support clinical decision-making, enhance the prediction of complication risks, and personalize treatment pathways [39–41].”
Health Care 2025: How Consumer-Facing Devices Change Health Management and Delivery
Trinh, S., Skoll, D., & Saxon, L. A. (2025) · Journal of Medical Internet Research · doi:10.2196/60766 · Cited by 10 · cited 1× · see citing works
“Professionals also reported a willingness to engage with new tools in general technology devices when training is adequate and when they are actively involved in implementation decisions in clinical and social decision [103–105].”
Food knowledge of patients at the first access to a Diabetology center.
Petrelli, F., Cangelosi, G., Scuri, S., et al. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i3-s.9418 · Cited by 9 · see citing works
Self-citationKomuro, K., Kaneko, H., Komuro, J., Suzuki, Y., Okada, A., Mizuno, A., Fujiu, K., Takeda, N., Morita, H., Node, K., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae221 · Cited by 7 · see citing works
Petersen, G. B., Joensen, L. E., Kristensen, J. K., Vorum, H., Byberg, S., Fangel, M. V., & Cleal, B. (2025) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.11.004 · Cited by 6 · cited 6× · see citing works
“The identified facilitators are an improved clinical efficiency [52,54,55], easiness of use [52,54], and the time sparing effect, both for the patient and for the physician [53,56,57].”
InfluentialSerin, O., Yıldırım, B. F., Duman, F., Ercorumlu, K., Yavas, R., Taşar, M. A., & Celik, M. S. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.106003 · Cited by 6 · cited 1× · see citing works
“This dual benefit supports both patients, who receive appropriate interventions sooner, and healthcare systems, which benefit from improved outcomes and resource efficiency [97].”
Hoffmeister, M. C., Lovison, V. H., Friedrich, E. P., & Rodrigues, T. D. C. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111873 · Cited by 5 · see citing works
Vanamali, D. R., Gara, H. K., & Dronamraju, V. A. C. (2025) · PubMed · doi:10.59556/japi.73.0909 · Cited by 5 · cited 1× · see citing works
“This reframing can help overcome cultural resistance to adoption, often rooted in concerns about professional identity and loss of autonomy [99,100].”
Elmotia, K., Abouyaala, O., Bougrine, S., & Ouahidi, M. L. (2025) · Primary care diabetes · doi:10.1016/j.pcd.2025.05.004 · Cited by 5 · cited 1× · see citing works
“In recent years, artificial intelligence (AI) has taken an increasingly prominent role in both diabetes research and clinical practice, owing to its capacity to process and analyze large volumes of clinical and behavioral data efficiently and accurately [35–38].”
Nair, P. M., Silwal, K., Kodali, P. B., Fogawat, K., Binna, S., Sharma, H., & Tewani, G. R. (2023) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2023.10.007 · Cited by 4 · cited 1× · see citing works
“Additionally, fragmented care coordination and lack of shared governance structures were seen as limiting factors in the effective deployment of AI across healthcare levels [101,102].”
Ratti, M., Ceriotti, D., Rescinito, R., et al. (2024) · Healthcare · doi:10.3390/healthcare12161650 · Cited by 4 · cited 1× · see citing works
“The introduction of AI and other technological tools into clinical settings—particularly for the management of chronic diseases—represents a significant opportunity to rethink traditional models of care and transition toward a more predictive, proactive, and personalized approach [84–89].”
Self-citationSaetang, T., Greeviroj, P., Thavaraputta, S., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15870 · Cited by 4 · cited 1× · see citing works
“In the context of T2D as well, digital technologies—including self-management applications and telemonitoring tools—are proving valuable, particularly in the personalization of therapeutic interventions and the optimization of clinical outcomes and complication management [31–34].”
Yang, Z., Tian, D., Zhao, X., et al. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-24-1406 · Cited by 4 · see citing works
Chimoriya, R., Rana, K., Adhikari, J., Aitken, S., Poudel, P., Baral, A., Rawal, L. B., & Piya, M. K. (2025) · Obesity Science & Practice · doi:10.1002/osp4.70046 · Cited by 4 · cited 1× · see citing works
“The majority of individuals with diabetes are obese and physically inactive, particularly within the 45–64 age group (28.9% of males and 32.8% of females) [6–8].”
InfluentialRafiei, S. K. S., Fateh, F., Arab, M., Espanlo, M., Dahaghin, S., Gilavand, H. K., Shahrokhi, M., Fallahi, M. S., Zardast, Z., Ansari, A., et al. (2024) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2024.31.3.2 · Cited by 3 · cited 2× · see citing works
“Devices such as continuous glucose monitoring (CGM) systems, insulin pumps (IP), and smart multiple daily injection (MDI) systems, often integrated into hybrid closed-loop systems, have become indispensable supports in daily clinical practice [21,22].”
Garabedian, P. M., Kain, J., Emani, S., Singleton, S., Rozenblum, R., Samal, L., & Mueller, S. K. (2025) · JMIR Human Factors · doi:10.2196/67884 · Cited by 2 · cited 1× · see citing works
“Without full connectivity between AI, electronic health records, and healthcare management systems, AI risks remaining an isolated technology, incapable of delivering real value to patient care [68,69].”
The Benefits and Challenges of Digitally-Enabled Cardiology
Castiello, T. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2024.0899 · Cited by 2 · cited 1× · see citing works
“However, without appropriate regulation and inclusive planning, the risk of exacerbating health inequities remains high—particularly in underserved or digitally marginalized populations [109,110].”
Blanken, C. P. S., Bayer, S., Carro, S. B., Hauner, H., & Holzapfel, C. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400561 · Cited by 1 · see citing works
Bech, A. A., Madsen, M. D., Kvist, A. V., Vestergaard, P., & Rasmussen, N. H. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70076 · Cited by 1 · cited 1× · see citing works
“While genetic predisposition and advancing age are recognized contributors to the pathogenesis of numerous chronic diseases such as diabetes [11,12], it is predominantly unhealthy lifestyle behaviors that significantly influence both the onset and progression of these conditions [13–17].”
Flagged first, then by citations
7 of the 119 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Perais, 2023, Prognostic Factors for the Development and Progression of Proliferative Diabetic Retinopathy in People with Diabetic Retinopathy, Cochrane Database Syst. Rev., 2023, CD013775
Cited by
Sorted by citations
Dinç, F., Kurt, A., & Şan, E. G. (2026) · CIN Computers Informatics Nursing · doi:10.1097/cin.0000000000001499 · Cited by 2 · see citing works
Young, C. F., & MacLeod, J. (2026) · International Journal of Obesity · doi:10.1038/s41366-026-02119-x · Cited by 1 · see citing works
“Poor integration causes friction that leads to abandonment regardless of AI capabilities [54, 55].”
Zhao, S., Cheang, C., 林靜儀, et al. (2026) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2026.1865219 · Cited by 1 · see citing works
“Even well-validated models fail when they do not align with EHR interfaces, generate excessive alerts or impose incremental work outside routine workflows (Cangelosi et al., 2025; Hassan et al., 2024).”
InfluentialEditorial for Special Issue “Advances in Public Health and Healthcare Management for Chronic Care”
Petrelli, F., & Cangelosi, G. (2025) · Medicina · doi:10.3390/medicina61101771
“The second section of this Special Issue features reviews, beginning with the scoping review by Cangelosi et al. [9], which examined barriers and facilitators to the implementation of artificial intelligence in diabetes management from the perspective of healthcare professionals, emphasizing both…”
Self-citationDiaconescu, B. M., Gurzu, B., Sava, C., Sava, C., Sfarghiu, I., Luchian, D., & Gurzu, I. L. (2025) · Romanian Journal of Occupational Medicine · doi:10.2478/rjom-2025-0001
van Treek, A., Verhagen, S. J. W., Lechner, L., Ruysseveldt, J. V., & Spronken, M. (2026) · doi:10.2196/preprints.105085
Malik, P. K., Bednarek, A., & Bednarek, K. (2026) · Polish Journal of Public Health · doi:10.12923/2083-4829/2026-0012
How AI reshapes clinical knowledge: a knowledge lifecycle model of AI adoption in hearing care
Talwar, S., Alkahtani, R., Alsaleh, H., et al. (2026) · Journal of Knowledge Management · doi:10.1108/jkm-03-2026-0530
Sun, Y., Yang, R., Xin, Q., Luo, X., Zhou, Y., Fu, Z., Li, J., Gu, Z., Liu, J., Wang, Q., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1919404
Talwar, S., Alsaleh, H., Dernóczi-Polyák, A., et al. (2026) · Journal of Knowledge Management · doi:10.1108/jkm-03-2026-0433
Martínez-Martínez, H., Alfonso, J. M., Sánchez-Rojo-Huertas, B., Visier‐Alfonso, M. E., Sebastián‐Valles, F., Díez‐Fernández, A., Perez-Moreno, A., & Martínez‐Vizcaíno, V. (2026) · Journal of Medical Internet Research · doi:10.2196/105329
“Although numerous quantitative studies have evaluated the clinical efficacy of these tools [17,18], evidence regarding human experience, specifically the perceptions, barriers, and facilitators of their adoption, remains fragmented and often limited to specific devices or user groups [19].”
Gautama, J., & Kartawiguna, D. (2026) · International Conference on Information Management and Technology (ICIMTech) · doi:10.1109/icimtech202671078.2026.11698937
Limiri, D. M. (2026) · Premier journal of science. · doi:10.70389/pjs.100280
- Authors
- Cangelosi, G., Conti, A., Caggianelli, G., Panella, M., Petrelli, F., Mancin, S., Ratti, M., & Masini, A.
- Affiliations
- Università di Camerino (IT)
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Azienda Ospedaliera San Giovanni Addolorata (IT)
- IRCCS Humanitas Research Hospital (IT)
- Corresponding author
- Panella, Massimiliano
- Petrelli, Fabio
- ORCID
- Venue
- Medicina
- Publisher
- MDPI AG
- Published
- 2025-08-01
- Volume
- 61
- Issue
- 8
- Pages
- 1403
- ISSN
- 1010-660X (ISSN-L)
- 1648-9144
- PMC
- PMC12387811
- OpenAlex
- W4412943687
- Semantic Scholar
- 432cdb9e064f20cea4e8aed6c8ef1e5fea14d3aa
- Cited by
- 14
- References
- 119
- Citations by year
- 2026: 11 · 2025: 3
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Medicina (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (submittedVersion, cc-by)
- PubMed Central (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Unicam Scientific Publications (University of Camerino) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
- Keywords
- artificial intelligence, diabetes management, technology adoption, barriers and facilitators, healthcare workers, bottom-up approach, organizational support, clinical teaching, data security, transparency in decision-making, clinical efficiency, AI acceptance
- MeSH terms
- Artificial Intelligence, Diabetes Mellitus, Health Personnel, Humans, Qualitative Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-13.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-13.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review